Cargando…
Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer’s Disease
BACKGROUND: Studies on the immunotherapy for Alzheimer’s disease (AD) have increasingly gained attention since 1990s. However, there are pros (preventing of AD) and cons (incurred cost and side effects) regarding the administration of immunotherapy. Up to date, there has been lacking of economic eva...
Autores principales: | Yang, Kuen-Cheh, Chen, Hsiu-Hsi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923704/ https://www.ncbi.nlm.nih.gov/pubmed/26825097 http://dx.doi.org/10.2174/1567205013666160129095012 |
Ejemplares similares
-
Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
por: Lin, Chung-Hsien, et al.
Publicado: (2019) -
Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil
por: da Silva, Luciana R., et al.
Publicado: (2018) -
Characteristics of falls in mild and moderate Alzheimer’s
disease
por: Kato-Narita, Eliane Mayumi, et al.
Publicado: (2009) -
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
por: Burstein, Aaron H, et al.
Publicado: (2014) -
Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
por: Young, Jonathan, et al.
Publicado: (2013)